Enter multiple symbols separated by commas

Search results for "ERT"



About 4 results. Sort By: Date | Relevance
UPDATE 3-Amicus to delay filing for U.S. marketing rights for lead drug

*Amicus unlikely to file application this year. Oct 2- Amicus Therapeutics Inc said it was unlikely to submit a U.S. marketing application for its lead drug, to treat Fabry disease, by the end of 2015 as expected, after U.S. health regulators asked for a more comprehensive analysis of trial data. Amicus's stock slumped as much as 59 percent to $5.69, at which point about...
Source: Reuters | By: Natalie Grover
UPDATE 2-Amicus expects delay in filing for marketing rights for lead drug

Oct 2- Amicus Therapeutics said it was unlikely to submit a marketing application for its lead drug by the end of the year as expected, after the U.S. Food and Drug Administration asked the company better compile its trial data. Amicus met with the FDA earlier this year to talk about migalastat's marketing application. However after reviewing of the minutes of...
Source: Reuters
UPDATE 3-Greece's Tsipras faces weary voters after reversal on bailout

By Michele Kambas and John Stonestreet. ATHENS, Sept 20- Greek leftist Alexis Tsipras made a last call on Sunday for weary voters to return him to power in a close-fought election, after a tumultuous year that saw him cave in to European demands for austerity to keep the country afloat. Tsipras was voted into office in January promising to halt austerity measures...
Source: Reuters
Greece's two heavyweights, deadlocked in polls, seek election soundbite

ATHENS, Sept 14- Greece's two political heavyweights will have undecided voters in their sights on Monday in a final televised head-to-head debate before national elections, both seeking the elusive soundbite that might break a deadlock in opinion polls. With Sunday's ballot looming, the leftist Syriza party of former prime minister Alexis Tsipras and the...
Source: Reuters | By: Renee Maltezou and John Stonestreet